On December 7, 2024, the "2024 Academic Annual Meeting of the Chronic Disease Management Branch of Tianjin Association of Traditional Chinese Medicine and the Construction Project Meeting of TCM Master Zhang Boli Studio and the Multi-dimensional Inheritance Research Project Meeting of Academic Thought and Experience of Zhang Boli School Members" was held in Tianjin.

Conference scene

Professor Jiang Feng, the inheritor of the academic experience of Professor Zhang Boli, the fifth batch of old Chinese medicine experts of the State Administration of Traditional Chinese Medicine, the director of TCM Master Zhang Boli Studio, the Secretary-General of the Education Steering Committee of the World Federation of Chinese Medicine Societies, and the vice president of the Chronic Disease Management Committee of the China Association of Traditional Chinese Medicine, delivered a speech, expressing a warm welcome to the experts attending the meeting, and made a wonderful report entitled "A Brief Analysis of the Theory of Turbid Phlegm and Drinking Diseases of Master Zhang Boli".

Professor Jiang Feng's speech

The conference was hosted by the Tianjin Association of Traditional Chinese Medicine, aiming to provide valuable academic resources and research directions for the Chinese medicine academic community, and to promote the sustainable development and prosperity of Chinese medicine. During the conference, a number of experts delivered keynote reports on the management of chronic diseases of traditional Chinese medicine, aiming to deepen cooperation and exchanges in the field of chronic diseases and promote the vigorous and rapid development of chronic disease management of traditional Chinese medicine in Tianjin.

Nanjing Ubond Pharm-tech Co., Ltd. participated in this meeting with the self-developed "Ubond" product, as a local brand in the field of anti-infection dressings for diabetic wounds. Xu Aihua, manager of the company, delivered a keynote speech entitled "100 Items in Ten Years to Promote Appropriate Technologies - Prevention of Diabetic Foot", sharing with the experts and scholars present the leading advantages of "Ubond" in the treatment of early wound infections in diabetic patients, preventing and reducing the occurrence of diabetic foot. As a new type of high-tech antibacterial medical dressing, "Ubond" has been approved as one of the 100 projects of the 10-year plan to promote appropriate technology for rural and urban communities, which fully demonstrates the advanced feature, practicability and social significance of its wide application

Xu Aihua, manager of Ubond, made a report to share

It is reported that there are about 140 million diabetic patients in China and the number is increasing year by year, and diabetic foot is one of the most serious complications of diabetes, and the severe ones even face the risk of amputation, which has become an important challenge to public health resources, and the state pays more than 500 billion yuan for treatment every year. The core technology of NOS nano-silver of "Ubond" brings a powerful, slow-release, hydrophilic anti-infection effect, which is a subversive innovation in wound care.

The conference also held academic exchanges, which enhanced the understanding of the core position of TCM chronic disease management in the modern medical system and the significant effect of the integration of traditional Chinese and Western medicine in disease prevention, and further emphasized the indispensability of the concept of "preventive treatment" in the modern medical system and the significance of this conference to the development of TCM.